ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)

$12.07 0.63 (5.507%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) News Sources

Enanta Pharmaceuticals Pitches RSV Phase 3 Plans, Expands Oral Immunology Pipeline at Citizens Conference

15-03-2026

marketbeat.com

Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)

30-03-2026

yahoo.com

Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026

07-04-2026

yahoo.com

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria

13-04-2026

yahoo.com

Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026

04-05-2026

yahoo.com

Enanta Pharmaceuticals (ENTA) Moves 5.3% Higher: Will This Strength Last?

07-05-2026

yahoo.com

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates

07-05-2026

yahoo.com

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026

11-05-2026

yahoo.com

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates

11-05-2026

yahoo.com

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

28-05-2026

yahoo.com

ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) Sentiment Trend

0 25 50 75 100 90 84 85 84 81 80 3 88 4 90 15-03-2026 30-03-2026 07-04-2026 13-04-2026 04-05-2026 07-05-2026 11-05-2026 28-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) FAQs

toggle

What is the current price of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)?

The current price of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) is $12.07.


toggle

ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) absolute price change since previous trading day?

The absolute price change of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) since the previous trading day is $0.63.


toggle

ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) percentage price change since previous trading day?

The percentage price change of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) since the previous trading day is 5.507%.


toggle

What is the most recent average sentiment score for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)?

The most recent average sentiment score for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)?

The most recent sentiment for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) is .


SEC-8K** Filing Available For ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.